Skip to content
The Policy VaultThe Policy Vault

Syprine (trientine hydrochloride)United Healthcare

Wilson’s disease (hepatolenticular degeneration)

Initial criteria

  • Diagnosis of Wilson’s disease (i.e., hepatolenticular degeneration)
  • AND History of intolerance, failure or contraindication to penicillamine

Reauthorization criteria

  • Documentation of positive clinical response to therapy

Approval duration

12 months